A nurse is reviewing the laboratory results of a client who has a new diagnosis of Hashimoto's disease. Which of the following lab results would the nurse expect to find?

Muscle hypertrophy (increase in muscle size) is not a typical manifestation of ALS. In fact, ALS leads to muscle atrophy (wasting) rather than hypertrophy. As motor neurons degenerate, muscles become weaker and smaller because they are no longer receiving adequate nerve signals to maintain strength.
B.A Tinnitus (ringing in the ears) is not a common manifestation of ALS. ALS primarily affects motor neurons and does not usually cause auditory symptoms. Tinnitus is more related to other conditions such as ear infections, exposure to loud noises, or certain neurological conditions, but it is not associated with ALS.
C. Tripping or stumbling is a common manifestation of ALS. As the disease progresses, it causes weakness in the muscles responsible for maintaining balance and coordination. This can lead to difficulties with walking and increased risk of tripping or falling.
D. Confusion is not a typical symptom of ALS. ALS primarily affects motor neurons, leading to muscle weakness and atrophy, but it does not usually affect cognitive function. However, in rare cases, some patients with ALS may develop cognitive or behavioral changes, but these are not the primary symptoms and are less common.
E. Dropping objects is a common manifestation of ALS. Muscle weakness and loss of fine motor control in the hands and arms can make it difficult to hold or manipulate objects, leading to frequent dropping.

A. Mucositis and diarrhea are side effects commonly associated with chemotherapy but are not directly related to myelosuppression. These symptoms are due to the impact of chemotherapy on rapidly dividing cells in the gastrointestinal tract.
B. Nausea and vomiting are common side effects of chemotherapy, primarily due to the treatment's impact on the gastrointestinal tract and the central nervous system.
C. Fever and chills are manifestations directly related to myelosuppression. Myelosuppression leads to a decrease in white blood cells (leukocytes), which compromises the immune system. This increased susceptibility to infection can result in symptoms such as fever and chills. These symptoms are indicative of potential infections or sepsis, which are more common in patients with compromised immune systems due to myelosuppression.

D. Alopecia (hair loss) and weight loss are common side effects of chemotherapy, but they are not directly related to myelosuppression. Alopecia results from the effects of chemotherapy on rapidly dividing hair follicle cells, while weight loss can be a consequence of changes in metabolism or appetite due to chemotherapy.